Long-term survival after LVAD for end-stage heart failure
Part of Heart & circulation clinical trials.
This trial looks at how well people with advanced heart failure do over the long term after getting a left-ventricular assist device (LVAD). Researchers will check blood and heart tissue samples to learn more about recovery and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Have end-stage heart failure that isn't improving with standard treatments
- Planning to get an LVAD as part of your normal care
- Able to give permission for the study and for collecting blood and heart tissue samples
- Willing to come for follow-up visits over a long period of time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares an LVAD device (a pump placed in the chest) plus medicines versus medicines alone for people with advanced, end-stage heart failure. It aims to see which approach works better to help patients live and stay out of the hospital.
This trial tests if metformin, a medicine commonly used for diabetes, can help improve heart function in people who have a mechanical heart pump (LVAD). You may be able to join if you are between 18 and 75, have a continuous-flow LVAD, and have a condition called insulin resistance (where your body doesn't use insulin well) but your blood sugar levels are well-controlled.
This trial studies how blood and heart tissue change in people with advanced heart failure who are getting an LVAD (a heart pump) or a heart transplant. It may help doctors better understand what’s happening in the heart before and after these treatments.
This study is testing a special palliative care program to help people with a heart pump (LVAD) feel better and improve their quality of life. If it works, the program could be used to support other LVAD patients in the future.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This study looks at an approach called “conditioning” using your LVAD (a heart pump) while you wait for a transplant. It aims to see whether your heart muscle may recover better during planned changes in support.
Hear when a new End-stage Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.